Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
TCT-166 Predictors of Target Lesion Revascularization After Implantation of Second-Generation Drug-Eluting Stents in Randomized Trials and the “Real-World”: Analysis From Two Large Datasets
Behnood Bikdeli, Ajay J. Kirtane, Shmuel Chen, Martin B. Leon, Patrick W. Serruys, Pieter C. Smits, Clemens von Birgelen, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Ori Ben‐Yehuda, Yangbo Liu, Björn Redfors, Thomas McAndrew, Gregg W. Stone (2018). TCT-166 Predictors of Target Lesion Revascularization After Implantation of Second-Generation Drug-Eluting Stents in Randomized Trials and the “Real-World”: Analysis From Two Large Datasets. Journal of the American College of Cardiology, 72(13), pp. B70-B71, DOI: 10.1016/j.jacc.2018.08.1278.
Article358 days agoLipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications
Mariana Pfeferman, Sina Rashedi, Professor Gregory Lip, C. Weber, Michelle L. O’Donoghue, Steven E. Nissen, Stephen J. Nicholls, Pradeep Natarajan, Jorge Plutzky, Peter Libby, Samuel Z. Goldhaber, Gregory Piazza, Behnood Bikdeli (2025). Lipoprotein(a) and Venous Thromboembolism: Association, Causality, and Medications. , 125(11), DOI: https://doi.org/10.1055/a-2674-5114.
Article21 days agoComparative Effectiveness Research Using Randomized Trials and Observational Studies: Validity and Feasibility Considerations
Behnood Bikdeli, Joseph S. Ross, Syed Bukhari, Molly M. Jeffery, Professor Gregory Lip, Seng Chan You, David J. Cohen, James L. Januzzi, Joshua D. Wallach (2025). Comparative Effectiveness Research Using Randomized Trials and Observational Studies: Validity and Feasibility Considerations. , 126(04), DOI: https://doi.org/10.1055/a-2664-7887.
Article21 days agoOptimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease
Azita H. Talasaz, Parham Sadeghipour, Luis Ortega‐Paz, Hessam Kakavand, Maryam Aghakouchakzadeh, Craig J. Beavers, John Fanikos, John W. Eikelboom, Deborah Siegal, Manuel Monréal, David Jiménez, Muthiah Vaduganathan, Lana A. Castellucci, Adam Cuker, Geoffrey D. Barnes, Jean M. Connors, Eric A. Secemsky, Benjamín Van Tassell, Raffaele De Caterina, Jacob E. Kurlander, Ali Aminian, Gregory Piazza, Samuel Z. Goldhaber, Lisa K. Moores, Saskia Middeldorp, Ajay J. Kirtane, Mitchell S.V. Elkind, Dominick J. Angiolillo, Stavros Konstantinides, Professor Gregory Lip, Gregg W. Stone, Mary Cushman, Harlan M. Krumholz, Roxana Mehran, Deepak L. Bhatt, Behnood Bikdeli (2024). Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease. , 21(8), DOI: https://doi.org/10.1038/s41569-024-01003-3.
Article21 days agoPB0014 Do Antiphospholipid Antibodies Inform the Choice of Anticoagulant Agents in Patients with Atrial Fibrillation?
Behnood Bikdeli, Antoine Bejjani, Candrika D. Khairani, D. Jimenez, Manuel Monréal, Deborah Siegal, Yogendra Kanthi, Geoffrey D. Barnes, M. O’Donoghue, Crystal A. Ruff, Saskia Middeldorp, Renato D. Lópes, Samuel Z. Goldhaber, Jeffrey I. Weitz, Mary Cushman, Harlan M. Krumholz, Professor Gregory Lip, Gregory Piazza (2023). PB0014 Do Antiphospholipid Antibodies Inform the Choice of Anticoagulant Agents in Patients with Atrial Fibrillation?. , 7, DOI: https://doi.org/10.1016/j.rpth.2023.100697.
Article21 days ago